Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria

BMC Health Services Research
Nicola BonnerJonathan A Bernstein

Abstract

The use of angiotensin-converting enzyme inhibitors (ACEI) has been associated with the development of bradykinin-mediated angioedema. With ever-widening indications for ACEI in diseases including hypertension, congestive heart failure and diabetic nephropathy, a concomitant increase in ACEI-Angioedema (ACEI-A) has been reported. At present there is no validated severity scoring or discharge criteria for ACEI-A. We sought to develop and validate an investigator rating scale with corresponding discharge criteria using clinicians experienced in treating ACEI-A. In-depth, 60-min qualitative telephone interviews were conducted with 12 US-based emergency physicians. Beforehand, clinicians were sent four case studies describing patients experiencing different severities of angioedema attacks. Clinicians were initially asked open-ended questions about their experience of patients' symptoms, treatment and discharge decisions. Clinicians then rated each patient case study and discussed patient diagnoses, ratings of symptom severity and discharge evaluation. The ratings were used to assess inter-rater reliability of the scale using the intra-class correlation coefficient (ICC) using IBM SPSS analysis Version 19 software. The findings pro...Continue Reading

References

Jul 1, 1996·Clinical Pharmacology and Therapeutics·N J BrownM R Griffin
Sep 12, 1998·Lancet·J NussbergerA Agostoni
Sep 3, 1999·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·E IshooN S Fuleihan
Aug 2, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A Agostoni, M Cicardi
Aug 23, 2002·The New England Journal of Medicine·Juerg NussbergerMarco Cicardi
Dec 13, 2006·Journal of Clinical Epidemiology·Caroline B TerweeHenrica C W de Vet
May 3, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Aleena BanerjiCarlos A Camargo
Jun 18, 2010·Journal of the American Academy of Dermatology·Peter W SchmidtFranz Trautinger
Dec 1, 2011·Current Allergy and Asthma Reports·Monali Vasekar, Timothy J Craig
Mar 1, 2012·The American Journal of Cardiology·James R RobertsDeborah A Marthers
May 23, 2012·Chemical Immunology and Allergy·Marianne Lerch
Apr 16, 2014·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Joseph J MoellmanRichard Sinert
Jul 26, 2014·The Annals of Otology, Rhinology, and Laryngology·Norman J Chan, Ahmed M S Soliman
Jan 21, 2015·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Jonathan A BernsteinChris J Lindsell
Jan 30, 2015·The New England Journal of Medicine·Murat BaşThomas K Hoffmann

❮ Previous
Next ❯

Citations

Mar 14, 2018·Health Services Research·James F BurgessMatthew L Maciejewski

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01919801

Software Mentioned

SPSS Statistics
Atlas
ti

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Atsushi YukimotoMasato Teraoka
Current Opinion in Allergy and Clinical Immunology
Paloma CampoCristobalina Mayorga
© 2022 Meta ULC. All rights reserved